|
|
 |
|
Viewing report
|
|
|
|
Clinical Decision Support Systems Markets in North America and Europe
Frost & Sullivan, Dec 2009, Pages: 101
This Frost & Sullivan research service titled Clinical Decision Support Systems Markets in North America and Europe provides a comprehensive analysis of the clinical decision support systems (CDSSs) markets in North America and Europe and discusses the opportunities within these markets from 2010-2016. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets by region: Europe - the United Kingdom, Germany, France, Italy, Spain, Scandinavia and Benelux and North America - the United States and Canada.
Market Overview
Clinical Decision Support Systems Gain Increased Recognition in Healthcare in North America and Europe
CDSSs are generally believed to support clinicians in making informed decisions and as such have the potential to influence the quality - the effectiveness, efficiency and economics - and, most importantly, the safety of healthcare. CDSS is useful for a variety of clinical activities such as preventive care, diagnostics, therapeutics, comprehensive disease management, image recognition and interpretation and prognostics. Theoretically, these systems can be used for any speciality of clinical care and in any setting, where the requisite knowledge base and technological infrastructure exist. The plasticity of this application suggests a diverse range of opportunities that influence the quality and safety of healthcare. “Health services need to find new, more cost-effective ways of delivering care due to the serious financial and resource implications of ageing populations, improved survival from a range of acute and long-term disorders, and the ever increasing array of treatment options now available,” says the analyst of this research. “Major national efforts are underway world-wide to promote the widespread and effective use of tools such as the electronic medical record and computerised physician order entry systems.”
Although computerising clinical data and transactions can substantially develop information management in patient care, CDSS reaches its full potential only when the relevant clinical knowledge is combined with the data to take informed healthcare decisions and actions. Furthermore, CDSS is proven effective in improving the outcomes at several state-of-the-art healthcare institutions by reducing adverse drug events, medication-related errors and costs by millions of dollars per year even within single hospitals. If these results are scaled up to a regional and national level, CDSSs have the potential to save thousands of lives and billions of dollars each year.
Clinical Decision Support Systems Vendors to Collaborate with Policy Makers to Address the Challenges
A major factor limiting the full adoption and impact of CDSS is the lack of a common and transportable base of clinical knowledge and clinical decision support interventions that can be easily and widely used in electronic health records and other clinical information systems. “Clinical knowledge and decision support interventions for use in clinical information systems can currently be obtained from a variety of sources whose formats are non-standard and accessibility is variable – healthcare IT vendor’s shared libraries, commercial decision support content publishers, and the Internet,” explains the analyst. “Largely, non-standardised and independent approaches to creating and presenting clinical knowledge and interventions severely limit incorporation, re-usability and interoperability in clinical information systems, presenting a major challenge for the CDSS market participants.”
Furthermore, clinicians sometimes resist the use of CDSSs, as they fear that these will reduce autonomy or increase liability. Several organisations do not recognise a clear business case for financial and organisational investments in developing and executing a plan to optimise CDSSs. Vendors of CDSSs should collaborate with policy makers to address these issues. “Similar to other health care information technologies, the costs associated with CDSS implementation are primarily borne by healthcare organisations while many of the benefits accrue to patients, payers and the society as a whole in terms of improved healthcare,” concludes the analyst. “Supportive policies and new financial incentives will help to redress these deficiencies and facilitate adoption of CDSS tools more swiftly and broadly.”
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
Europe
- The United Kingdom
- Germany
- France
- Italy
- Spain
- Scandinavia
- Benelux
North America
- The United States
- Canada
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
2012 Deep Research Report on Global and China Hemodialysis Machine Industry
Orthopedic Joint (Hip and Knee) Reconstruction Devices Markets Worldwide
Mechanical Ventilators, Disposables and Services Markets Worldwide
U.S. Ambulatory EHR Market
Healthcare IT Global Market Briefing to 2016
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues
U.S. Hospital EHR Market 2009-2016
Overview of the South Korean RIS-PACS Market
The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
Chinese Above-the-neck PPE Markets
|
|
|
|
